StonvexLoading…
StonvexStonvexStonvexCore line items from URBN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-25 | Annual 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|---|
Revenue | $1.68B | $6.17B | $4.36B | $2.83B | $1.33B |
Operating Income | Not available | $605.63M | $446.93M | $302.61M | $128.23M |
Net Income | Not available | $464.92M | $368.65M | $252.21M | $108.35M |
EPS (Diluted) | $1.73 | $5.06 | $4.01 | $2.73 | $1.16 |
Total Assets | Not available | $5.01B | $4.91B | $4.71B | $4.46B |
Total Liabilities | Not available | $2.19B | $2.20B | $2.13B | $2.03B |
Cash & Equivalents | Not available | $369.21M | $306.60M | $332.17M | $189.43M |
Free Cash Flow OCF − CapEx | Not available | $315.02M | $120.74M | $143.50M | $-13.13M |
Shares Outstanding | Not available | 89.70M | 89.71M | 89.70M | 89.61M |